CAMBRIDGE, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics (AKBA) ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results